Tag: life sciences

September 8, 2021: Amazon Elasticsearch Service has been renamed to Amazon OpenSearch Service. See details. This is the first post of a four-part series on the strategic collaboration between AWS and Novartis AG, where the AWS Professional Services team built the Buying Engine platform. In this series: Part 1: How Novartis AG brought SMART into […]

Background Traditional assessments of disease progression and intervention efficacy used in clinical trials are often limited. These assessments normally consist of clinical outcome assessments (COAs) and patient reported outcomes (PROs). COAs are physician-derived, often requiring patients to travel to a clinical site. They are typically subjective, episodic in nature, and provide limited insight into the […]

Bob Reiter, Head of R&D of Bayer Crop Science, joins Elizabeth Fastiggi, Worldwide Lead of Agriculture Business at AWS for a discussion on recent disruptions in the global food supply chain, examples of farmers building resiliency through data and analytics, and future trends for sustainability. Crop Science, a division of Bayer, provides a range of […]

AWS Genomics has released a new whitepaper, Genomics Data Transfer, Analytics, and Machine Learning using AWS Services, that provides essential information and guidance on how to build a Next Generation Sequencing (NGS) platform using AWS services, from instrument to interpretation. Accompanying the new whitepaper are three solutions, developed based on feedback from AWS life science […]

AWS re:Invent routinely fills several Las Vegas venues with standing-room only crowds, but we are bringing it to you with an all-virtual and free event this year. This year’s conference is gearing up to be our biggest yet and we have an exciting program planned with five keynotes, 18 leadership sessions, and over 500 breakout […]

Introduction Bio-pharmaceutical companies have always had a responsibility to report adverse events (AE), whether in clinical development or post market-approval scenarios, to the Food and Drug Administration (FDA).  The COVID-19 pandemic and the race to find effective treatments for this disease has caused both the FDA and bio-pharmaceutical organizations around the world to re-imagine the […]

Co-authored by Grace Tiao, Associate Director of Computational Genomics at the Broad Institute and Erin Chu, DVM, Ph.D., Life Sciences Lead, AWS Open Data Program Today we announce that data from the Genome Aggregation Consortium (gnomAD) is available for the first time on Amazon Web Services (AWS) as part of the Registry of Open Data […]

September 8, 2021: Amazon Elasticsearch Service has been renamed to Amazon OpenSearch Service. See details. Life Science companies are witnessing substantial growth in number of Adverse Events (AE) being reported for their products. This may be due to the increase in data volumes coming from journals, articles, social media, and non-standardized data sources. Evolving regulations […]

Introduction Bringing a new drug to market is a slow and laborious process. According to Tufts Centre for the Study of Drug Development, it takes on average between 7 to 10 years and costs more than $2.5 billion to bring a new drug to market. (1) More than half of this time and capital is […]

The Dark Data Problem Up to 80% of your organization’s medical patient data is untapped, undervalued, or unused Imagine walking into a physician’s office for a checkup. As you describe some pain you’ve been having in your left knee, the doctor barely looks up from the screen as she clatters away on the keyboard, taking […]